Drawing for COLD-FIX

USPTO serial 79221633

COLD-FIX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MACFARLANE, JAMES W
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with COLD-FIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Sanitary preparations for medical purposes; disinfectants; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses such as varicella and infectious mononucleosis; pharmaceutical preparations for prevention and treatment of enterovirus, rotavirus, coronavirus, and adenoviral diseases; pharmaceutical preparations for prevention and treatment of diseases caused by tick-borne encephalitis virus, calicivirus, and respiratory viruses; antibody-based pharmaceutical preparations for the treatment of infectious diseases; antibody-based pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses such as varicella and infectious mononucleosis; antibody-based pharmaceutical preparations for the prevention and treatment of enterovirus, rotavirus, coronaviruses, and adenoviral diseases; antibody-based pharmaceutical preparations to prevent and treat diseases caused by tick-borne encephalitis virus, calicivirus, and respiratory viruses; drugs for the treatment of AIDS/HIV infection; antibody-based pharmaceutical preparations for the treatment of AIDS/HIV infection; pharmaceutical preparations for the treatment of viral hepatitis; antibody-based pharmaceutical preparations for the treatment of viral hepatitis; pharmaceutical preparations for the treatment of influenza; antibody-based drugs pharmaceutical preparations for the treatment of influenza; disinfectants for hygiene purposes, including disinfectants fighting microorganisms which cause infectious disease in man; immunomodulators; anti-mutagenic pharmaceutical preparations for the prevention and treatment of infectious diseasesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 30, 2021FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
May 10, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 8, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 8, 2020MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
May 8, 2020ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
May 8, 2020OP.TOPPOSITION TERMINATED NO. 999999—
May 8, 2020OP.DOPPOSITION DISMISSED NO. 999999—
Apr 21, 2020LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Feb 7, 2020LIMGLIMITATION OF GOODS RECEIVED FROM IB—
May 10, 2019OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 24, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 24, 2019OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 8, 2018RFNTREFUSAL PROCESSED BY IB—
May 17, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
May 16, 2018OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
May 16, 2018OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
May 4, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 3, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 3, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 3, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 14, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 28, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 7, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 6, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 6, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 1, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 1, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 1, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 19, 2018RFNPREFUSAL PROCESSED BY IB—
Jan 11, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 10, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 10, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 30, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 30, 2017RFRRREFUSAL PROCESSED BY MPU—
Dec 19, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 15, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 14, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 7, 2017DOCKASSIGNED TO EXAMINER—
Dec 7, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 23, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance